Form 4 filings across 6 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$219.1K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 32 most recent Form 4 transactions.
| Dec 12, 2025 | MRUS | Merus N.V. | DTOISS◆ | 8,500 | — | — | — | Open the original filing on SEC.gov |
| Dec 12, 2025 | MRUS | Merus N.V. | DTOISS◆ | 4,983 | — | — | — | Open the original filing on SEC.gov |
| Dec 12, 2025 | MRUS | Merus N.V. | DTOISS◆ | 5,650 | — | — | — | Open the original filing on SEC.gov |
| Dec 12, 2025 | MRUS | Merus N.V. | DTOISS◆ | 8,631 | — | — | — | Open the original filing on SEC.gov |
| Dec 12, 2025 | MRUS | Merus N.V. | DTOISS◆ | 6,120 | — | — | — | Open the original filing on SEC.gov |
| Dec 12, 2025 | MRUS | Merus N.V. | DTOISS◆ | 16,604 | — | — | — | Open the original filing on SEC.gov |
| Dec 12, 2025 | MRUS | Merus N.V. | DTOISS◆ | 14,414 | — | — | — | Open the original filing on SEC.gov |
| Dec 12, 2025 | MRUS | Merus N.V. | DTOISS◆ | 8,844 | — | — | — | Open the original filing on SEC.gov |
| Dec 12, 2025 | MRUS | Merus N.V. | DTOISS◆ | 13,193 | — | — | — | Open the original filing on SEC.gov |
| Dec 12, 2025 | MRUS | Merus N.V. | UTENDR | 73,576 | $97.00 | $7.1M | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 76,227 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 11,493 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 70,587 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 13,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 13,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 26,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 9,398 | — | — | -100.0% | Open the original filing on SEC.gov |
| Oct 23, 2025 | KALA | KALA BIO, Inc. | SSELL | 154,894 | $0.81 | $125.5K | -59.9% | Open the original filing on SEC.gov |
| Oct 23, 2025 | QTTB | Q32 Bio Inc. | AGRANT◆ | 53,521 | — | — | — | Open the original filing on SEC.gov |
| Aug 11, 2025 | THRD | Third Harmonic Bio, Inc. | JOTHER◆ | 83,296 | — | — | — | Open the original filing on SEC.gov |
| Aug 11, 2025 | THRD | Third Harmonic Bio, Inc. | JOTHER | 128,631 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jun 24, 2025 | KALA | KALA BIO, Inc. | SSELL◷? | 13,227 | $4.01 | $53K | -4.9% | Open the original filing on SEC.gov |
| Jun 15, 2025 | KALA | KALA BIO, Inc. | AGRANT◆ | 5,450 | — | — | — | Open the original filing on SEC.gov |
| Jun 15, 2025 | KALA | KALA BIO, Inc. | AGRANT | 2,450 | — | — | +0.9% | Open the original filing on SEC.gov |
| Jun 3, 2025 | KALA | KALA BIO, Inc. | SSELL◷?↺ | 10,866 | $3.74 | $40.6K | -3.9% | Open the original filing on SEC.gov |
| Jun 3, 2025 | AKRO | Akero Therapeutics, Inc. | AGRANT | 9,398 | — | — | — | Open the original filing on SEC.gov |
| May 22, 2025 | MRUS | Merus N.V. | AGRANT◆ | 13,193 | — | — | — | Open the original filing on SEC.gov |
| Feb 21, 2025 | IKT | Inhibikase Therapeutics,… | AGRANT◆↺ | 602,346 | — | — | — | Open the original filing on SEC.gov |